We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-1.38%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$97.1B
AUM Growth
+$19.4B
(+25%)
Cap. Flow
+$24.4B
Cap. Flow
% of AUM
25.14%
Top 10 Holdings %
Top 10 Hldgs %
12.02%
Holding
3,234
New
374
Increased
1,828
Reduced
905
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$474M |
| 2 |
Snowflake
SNOW
|
+$418M |
| 3 |
General Motors
GM
|
+$395M |
| 4 |
Roblox
RBLX
|
+$378M |
| 5 |
Adobe
ADBE
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMAR
Smartsheet Inc.
SMAR
|
+$173M |
| 2 |
Progressive
PGR
|
+$158M |
| 3 |
Robinhood
HOOD
|
+$155M |
| 4 |
AbbVie
ABBV
|
+$131M |
| 5 |
Lennar Class A
LEN
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.11% |
| 2 | Financials | 16.12% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 11.39% |
| 5 | Industrials | 11.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JBIO
3076
Jade Biosciences
JBIO
$1.36B
| $54.3K | ﹤0.01% |
618
+79
| +15% | +$6.94K |
|
3077
Alta Equipment Group
ALTG
$249M
| $54K | ﹤0.01% |
11,522
-73,955
| -87% | -$461K |
|
3078
Nerdy
NRDY
$95M
| $53.5K | ﹤0.01% |
37,660
+15,234
| +68% | +$25.6K |
|
3079
Century Therapeutics
IPSC
$372M
| $52.9K | ﹤0.01% |
111,079
+86,875
| +359% | +$65.3K |
|
3080
Alto Neuroscience
ANRO
$1.12B
| $52.1K | ﹤0.01% |
+24,099
| New | +$86.2K |
|
3081
Fulcrum Therapeutics
FULC
$282M
| $50.7K | ﹤0.01% |
17,608
-28,033
| -61% | -$103K |
|
3082
Clover Health Investments
CLOV
$2.33B
| $48.7K | ﹤0.01% |
+13,576
| New | +$54.5K |
|
|
HLVX
3083
DELISTED
HilleVax
HLVX
| $48.6K | ﹤0.01% |
33,495
+9,228
| +38% | +$17.1K |
|
3084
4D Molecular Therapeutics
FDMT
$600M
| $46.3K | ﹤0.01% |
+14,340
| New | +$67.6K |
|
3085
ProKidney
PROK
$330M
| $46.1K | ﹤0.01% |
52,570
+27,098
| +106% | +$37.6K |
|
3086
Acumen Pharmaceuticals
ABOS
$178M
| $45.9K | ﹤0.01% |
+41,735
| New | +$59.6K |
|
3087
PLAYSTUDIOS Inc
MYPS
$81.1M
| $45.6K | ﹤0.01% |
35,903
+4,147
| +13% | +$6.75K |
|
3088
LanzaTech
LNZA
$69M
| $44.6K | ﹤0.01% |
1,843
+1,682
| +1,045% | +$151K |
|
3089
Biote Corp
BTMD
$46.7M
| $42.9K | ﹤0.01% |
+12,871
| New | +$61.4K |
|
3090
Roadzen
RDZN
$112M
| $42.2K | ﹤0.01% |
40,559
+13,830
| +52% | +$18.6K |
|
3091
Southland Holdings
SLND
$38.5M
| $42K | ﹤0.01% |
+14,061
| New | +$45.7K |
|
3092
AlTi Global
ALTI
$451M
| $41.5K | ﹤0.01% |
+13,651
| New | +$48.9K |
|
3093
Clear Channel Outdoor Holdings
CCO
$1.23B
| $41.3K | ﹤0.01% |
37,178
-408,235
| -92% | -$539K |
|
3094
Shattuck Labs
STTK
$686M
| $41K | ﹤0.01% |
43,169
+31,355
| +265% | +$38.6K |
|
3095
Offerpad Solutions
OPAD
$23M
| $40.4K | ﹤0.01% |
2,431
+998
| +70% | +$21.7K |
|
3096
SkinHealth Systems
SKIN
$91.1M
| $40.2K | ﹤0.01% |
+29,972
| New | +$45.7K |
|
3097
Pyxis Oncology
PYXS
$179M
| $39.5K | ﹤0.01% |
40,270
-9,810
| -20% | -$13.1K |
|
3098
Telos
TLS
$321M
| $39.3K | ﹤0.01% |
+16,495
| New | +$50.6K |
|
|
QIPT
3099
DELISTED
Quipt Home Medical
QIPT
| $38.1K | ﹤0.01% |
16,367
+5,749
| +54% | +$15.8K |
|
|
GBIO
3100
DELISTED
Generation Bio
GBIO
| $36K | ﹤0.01% |
+8,901
| New | +$62.5K |
|
Similar funds
VGA
AQR Capital Management's Q1 2025 Portfolio in Review
As of Q1 2025, AQR Capital Management held 3,234 positions worth $97.1B, up 25% from $77.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
AQR Capital Management deployed $24.4B of net new capital in Q1 2025, opening 374 new positions and adding to 1,828 existing holdings. Its largest new stake was Millrose Properties Inc: 1,839,302 shares worth $48.4M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Progressive, an estimated $158M trimmed.
- AQR Capital Management's largest Q1 2025 buy was Millrose Properties Inc: 1,839,302 shares worth $48.4M.
- AQR Capital Management added most to Arista Networks in Q1 2025, an estimated $474M increase.
- AQR Capital Management's biggest Q1 2025 reduction was Progressive, cutting an estimated $158M.
- AQR Capital Management fully exited Smartsheet Inc. in Q1 2025, selling an estimated $173M.
- AQR Capital Management's ten largest holdings make up 12% of its $97.1B portfolio in Q1 2025.
- AQR Capital Management opened 374 new positions and closed 84 in Q1 2025.
- AQR Capital Management's portfolio value rose 25% quarter-over-quarter to $97.1B.
Based on AQR Capital Management's 13F filing for Q1 2025, filed 15 May 2025.